THOMAS CONTRACTING LIMITED

Here is a comprehensive financial health assessment for Thomas Contracting Limited, evaluating the company’s vital signs and overall financial wellness using a diagnostic approach.

1. Financial Health Score: A-

Explanation: Thomas Contracting Limited is in excellent physical condition, demonstrating vigorous growth and robust profitability. The company has successfully navigated recent industry inflation and grown its underlying contracting work by 30%. The balance sheet is highly muscular, with equity nearly doubling in the last year. The only reason this is not a perfect A+ is due to a relatively thin cash buffer relative to its massive turnover, meaning it relies on a parent company "life support" system (an asset-based lending facility) to manage day-to-day working capital. This is common in the construction industry, but requires ongoing monitoring.

2. Key Vital Signs

• Heart Rate (Revenue Growth): Beating strongly and accelerating. Total turnover jumped to £49.7m (from £34m in 2024). Stripping out wage and subcontractor recharges, the core contracting work grew 30% to £33.3m. This shows a healthy, expanding appetite for work.
• Blood Pressure (Profitability & Margins): Healthy and well-regulated. Profit before tax rose to £3.2m, up from £2.1m the previous year. The directors note that margins improved due to relief on material costs and a calming of inflation. A £3.2m profit on £33.3m of core contracting work yields a highly respectable margin of nearly 10%.
• Cholesterol Levels (Leverage & Liabilities): Low and manageable. Total liabilities stand at £3.88m, down slightly from £4.12m, despite a massive increase in business activity. The company is not over-leveraged and is effectively managing its debt load.
• Oxygen Saturation (Cash & Liquidity): Adequate, but requiring assisted breathing. Cash on hand increased to £563,914 (up from £296,898). However, against a £49.7m turnover, this is a very thin oxygen supply. The company relies on an asset-based lending facility secured by its parent company in 2022 to fund working capital fluctuations.
• Muscle Mass (Net Assets/Equity): Excellent. Shareholders' funds nearly doubled, jumping from £3.58m to £6.73m. The business is rapidly building its financial immune system and net worth.

3. Diagnosis

Overall Condition: Robust and expanding, with excellent post-pandemic recovery and growth.

Symptoms Analysis: The primary symptom here is hyper-growth. Growing turnover by 46% in a single year is a great "problem" to have, but rapid expansion consumes working capital (cash) at an accelerated rate. The financial data reveals a company that is growing faster than its internal cash generation can self-fund.

Fortunately, the diagnosis is not distress. The business has anticipated this cash crunch and proactively secured backing from its parent company, Thomas Holdings (North West) Limited. The parent's asset-based lending facility acts as a financial ventilator, ensuring the company has the liquidity to take on large contracts without suffocating. Furthermore, the decision not to pay dividends for the year ending May 2025 was a highly prudent clinical decision, keeping vital nutrients (profits) inside the body to fund growth rather than extracting them.

Prognosis: The future outlook is highly positive. The company has a strong forward order book of £19m secured for the next 15 months, plus £9.5m out on quote. The directors report that trading has remained profitable into late 2025 with stronger margins. Assuming the parent company's lending facility remains intact and clients pay on time, the company is well-positioned for sustained financial health.

4. Recommendations

To maintain and improve financial wellness, the following preventative measures are recommended:

• Hydration Therapy (Cash Buffering): While the parent facility provides a safety net, aim to gradually build independent cash reserves. A cash balance of £500k on a £50m turnover leaves little room for error if a major client delays payment. Retaining a portion of future profits will build a stronger independent immune system.
• Circulatory Health (Credit Control): The directors mention regular credit control, which is vital. In construction, late payments act like restricted blood flow. Continue strict monitoring of trade debtors and consider incentivizing early client payments to bring cash into the business faster.
• Dietary Adjustments (Recharge Management): With £16.4m of turnover consisting of wage and subcontractor recharges, ensure these pass-through costs are not artificially inflating top-line revenue without contributing to gross profit. Keep a close eye on the underlying margin to ensure administrative burden is properly compensated.
• Capacity Monitoring (Operational Health): With a £19m order book, the primary risk shifts from financial to operational. Ensure the company has the subcontractor capacity and project management bandwidth to deliver these contracts on time, as delays can quickly erode the healthy margins currently being enjoyed.